Arkolith/Insider Trading/HEPA/Form 4

Wijngaard Peter

DirectorHepion Pharmaceuticals, Inc. (HEPA) · full profile →Form 4 · filed Sep 20, 2023
Net Buying
Open-Market Buys
$17K
Open-Market Sells
$0
Net Open-Market Flow
$17K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2023Buy(P)1K$5.64$6K5K
Sep 15, 2023Buy(P)861$5.37$5K4K
Sep 15, 2023Buy(P)139$5.45$7583K
Sep 15, 2023Buy(P)1K$5.82$6K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-102209) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML